Abstract
Polypeptide chain fragments of recombinant transthyretin (TTR) with leucine-55 substituted by proline (L55P), which are involved in abnormal fibrillogenesis of this protein, were studied. No fibrils were produced in purified preparations of TTR(L55P) under the optimum conditions for fibrillogenesis but in absence of protease inhibitors. The ability of TTR for fibrillogenesis was lost because of a limited proteolysis resulting in detachment of the TTR polypeptide chain C-terminal fragment of ∼18 amino acid residues in length. This proteolysis seemed to occur with involvement of a bacterial serine endopeptidase sohB (EC 3.4.21), which was identified in TTR preparations by the MALDI-TOF method. The presence of the C-terminal fragment of the TTR polypeptide chain seems to be crucial for production of abnormal fibrils.
Similar content being viewed by others
Abbreviations
- MALDI-TOF:
-
Matrix-Assisted Laser Desorption/Ionization-Time of Flight
- ThT:
-
thioflavin T
- TTR:
-
transthyretin
- TTR(L55P):
-
transthyretin with leucine-55 substituted by proline
References
Koo, E. H., Lansbury, P. T., Jr., and Kelly, J. W. (1999) Proc. Natl. Acad. Sci. USA, 96, 9989–9990.
Dwulet, F.E., and Benson, M. D. (1983) Biochem. Biophys. Res. Commun., 114, 657–662.
Lai, Z., Colon, W., and Kelly, J. W. (1996) Biochemistry, 35, 6470–6482.
Dobson, C. M. (1999) Trends Biochem. Sci., 24, 329–332.
Kelly, J. W., and Lunsbury, P. T. (1994) Amyloid, 1, 186–205.
Zheng, W., Lu, Y., Lu, G., Zhao, Q., Cheung, O., and Blaner, W. (2001) Toxicol. Sci., 61, 107–114.
Skoulakis, S., and Goodfellow, J. M. (2003) Biophys. J., 84, 2795–2804.
Hornberg, A., Hultdin, U. W., Olofsson, A., and Sauer-Eriksson, A. E. (2005) Biochemistry, 44, 9290–9299.
Joao, M., and Saraiva, M. (1995) Hum. Mutat., 5, 191–196.
Bergquist, J., Andersen, O., and Westman, A. (2000) Clin. Chem., 46, 1293–1300.
Misu, K., Hattori, N., Nagamatsu, M., Ikeda, S., Ando, Y., Nakazato, M., Takei, Y., Hanyu, N., Usui, Y., Tanaka, F., Harada, T., Inukai, A., Hashizume, Y., and Sobue, G. (1999) Brain, 122, 1951–1962.
Lashuel, H. A., Wurth, C., Woo, L., and Kelly, J. W. (1999) Biochemistry, 38, 13560–13573.
Serag, A. A., Altenbach, C., Gingery, M., Hubbel, W. L., and Yeatis, T. O. (2002) Natl. Struct. Biol., 9, 734–739.
White, J. T., and Kelly, J. W. (2001) Proc. Natl. Acad. Sci. USA, 98, 13019–13024.
Rosen, H. N., Moses, A. C., Murell, J. R., Liepnieks, J. J., and Benson, M. D. (1993) J. Clin. Endocrinol. Metab., 77, 370–374.
Olofsson, A., Ippel, H. J., Baranov, V., Horstedt, P., Wijmenga, S., and Lundgren, E. (2001) J. Biol. Chem., 276, 39592–39599.
Quintas, A., Saraiva, M. J., and Brito, R. M. (1999) J. Biol. Chem., 274, 32943–32949.
Quintas, A., Vaz, D. C., Cardoso, I., Saraiva, M. J., and Brito, R. M. (2001) J. Biol. Chem., 276, 27207–27213.
Hurshman, A. R., White, J. T., Powers, E. T., and Kelly, J. W. (2004) Biochemistry, 43, 7365–7381.
Lindgren, M., Sorgjerd, K., and Hammarstrom, P. (2005) Biophys. J., 88, 4200–4212.
Serpell, L. C., Sunde, M., Benson, M. D., Tennent, G. A., Pepys, M. B., and Fraser, P. E. (2000) J. Mol. Biol., 300, 1033–1039.
Jarvis, J. A., Craik, D. J., and Wilce, M. C. (1993) Biochem. Biophys. Res. Commun., 192, 991–998.
Jaroniec, C. P., MacPhee, C. E., Astrof, N. S., Dobson, C. M., and Griffin, R. (2002) Proc. Natl. Acad. Sci. USA, 99, 16748–16753.
Jaroniec, C. P., MacPhee, C. E., Bajaj, V. S., McMahon, M. T., Dobson, C. M., and Griffin, R. (2004) Proc. Natl. Acad. Sci. USA, 101, 711–716.
MacPhee, C., and Dobson, C. M. (2000) Chem. J. Mol. Biol., 297, 1203–1215.
Dirix, C., Meersman, F., MacPhee, C., Dobson, C. M., and Heremans, K. (2005) J. Mol. Biol., 347, 903–909.
Schwarzman, A. L., Tsiper, M., Wente, H., Wang, A., Vitek, M. P., Vasiliev, V., and Goldgaber, D. (2004) Amyloid, 11, 1–9.
Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) in Molecular Cloning, USA Cold Spring Harbor Laboratory Press, N. Y., pp. 174–175.
Hammarstrom, P., Jiang, X., Hurshman, A. R., Powers, E. T., and Kelly, J. W. (2002) Proc. Natl. Acad. Sci. USA, 99, 16427–16432.
LeVine, H. (1993) Protein Sci., 2, 404–410.
Baird, L., Lipinska, B., Raina, S., and Georgopoulos, C. (1991) J. Bacteriol., 173, 5763–5770.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © K. V. Solovyov, A. A. Gasteva, V. V. Egorov, T. D. Aleinikova, A. K. Sirotkin, A. L. Shvartsman, M. M. Shavlovsky, 2006, published in Biokhimiya, 2006, Vol. 71, No. 5, pp. 672–680.
Rights and permissions
About this article
Cite this article
Solovyov, K.V., Gasteva, A.A., Egorov, V.V. et al. Role of the C-terminal fragment of human transthyretin in abnormal fibrillogenesis. Biochemistry (Moscow) 71, 543–549 (2006). https://doi.org/10.1134/S0006297906050129
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1134/S0006297906050129